Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
MN.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
MN.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
MN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MN.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.63ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.63ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.63ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.63NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LE.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LE.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LE.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LE.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LH.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LH.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LH.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LH.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HW.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HW.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HW.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HW.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.55.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.55.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.55.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.55.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.18.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.18.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.18.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.18.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDK.4.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDK.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDK.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDK.4.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.3.4.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.3.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.3.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.4.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.2.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.2.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LS.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LS.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LS.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LS.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.1 (Omicron)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.1 (Omicron)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1 (Omicron)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1 (Omicron)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used